Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKılıç, Salih
dc.contributor.authorSümerkan, Mutlu Çağan
dc.contributor.authorEmren, Sadık Volkan
dc.contributor.authorBekar, Lütfü
dc.contributor.authorÇerşit, Sinan
dc.contributor.authorTunç, Elif
dc.contributor.authorGök, Gülay
dc.contributor.authorAltuntaş, Emine
dc.contributor.authorCanpolat, Uğur
dc.contributor.authorSinan, Ümit Yaşar
dc.contributor.authorÖzmen, Namık
dc.contributor.authorZoghi, Mehdi
dc.date.accessioned2019-05-13T09:07:17Z
dc.date.available2019-05-13T09:07:17Z
dc.date.issued2019
dc.identifier.citationKılıç, S., Sümerkan, M. Ç., Emren, V., Bekar, L., Çerşit, S., Tunç, E., Gök, G., Altuntaş, E. [et al.]. (2019). Secondary prevention of coronary heart disease in elderly population of Turkey: A subgroup analysis of ELDERTURK study. Cardiology Journal, 26(1), 13-19.en_US
dc.identifier.issn1897-5593
dc.identifier.urihttps://doi.org/10.5603/CJ.a2017.0113
dc.identifier.urihttps://hdl.handle.net/11491/1769
dc.description.abstractBackground: Secondary prevention plays an important role after acute coronary event due to high risk of adverse events in elderly. In present study we aimed to evaluate the lifestyle, management of risk factors and medical treatment for secondary protection in elderly patients with known coronary heart disease (CHD). Methods: ELDERTURK is a non-interventional, multi-centered, observational study, which included total of 5694 elderly patients (> 65 years) from 50 centers in Turkey. In this study elderly patients from the ELDERTURK population with known CHD were evaluated for cardiovascular risk factors, comorbidities and medication usage. Results: A total of 2976 (52.3% of study) out of 5694 patients included in the ELDERTURK study were evaluated. All had known CHD with a mean age of 73.4 ± 6.2 years and 60.3% were male. 13.0% of patients were smokers, 42.4% were overweight and 21.1% were obese. Only 23.6% of patients reported to do regular exercise, 73.4% had history of hypertension, 47.4% had dyslipidemia and 33.9% had diabetes mellitus. The rate of patients with systolic blood pressure > 140 mmHg were 31.1% and only 13.9% of patients had a recommended ? 70 mg/dL level of low-density lipoprotein cholesterol. Antiplatelet, statin, beta-blocker and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker usage was limited to 27.3%. Conclusions: The ELDERTURK study shows that many patients with CHD have a high prevalence of modifiable risk factors and unhealthy lifestyle. Apart from this, many patients are not receiving therapeutic intervention and as a consequence most were not achieving the recommended goals. © 2019 Via Medica.en_US
dc.language.isoeng
dc.publisherVia Medicaen_US
dc.relation.isversionof10.5603/CJ.a2017.0113en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAgingen_US
dc.subjectCoronary Diseaseen_US
dc.subjectDrugsen_US
dc.subjectEpidemiologyen_US
dc.subjectPreventionen_US
dc.subjectTreatmenten_US
dc.titleSecondary prevention of coronary heart disease in elderly population of turkey: A subgroup analysis of Elderturk studyen_US
dc.typearticleen_US
dc.relation.journalCardiology Journalen_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.identifier.volume26en_US
dc.identifier.issue1en_US
dc.identifier.startpage13en_US
dc.identifier.endpage19en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster